• ePatientFinder and Rep Network Partner to Expand Clinical Trial Access

    Apr 18, 2017, 09:56 by Michael Croft
    AUSTIN, TX, UNITED STATES - Apr 18, 2017 - ePatientFinder®, the leader in EHR-driven clinical trial site optimization and patient identification, and Rep Network, the independent sales and knowledge source for the healthcare industry, today announced an alliance that will expand clinical trial access to millions of additional patients across the country
    Full story

  • China To Tighten Rules Against Faking Clinical Trial Data, Criminal Charges Possible

    Apr 13, 2017, 14:48 by Michael Croft
    FierceBiotech |  China's FDA and Supreme Court, in a seemingly synchronized move, are proposing new actions against forging clinical trial data, and criminal charges are on the table.
    Full story

  • BioreclamationIVT Signs Exclusive Agreement to Distribute Cellaria Cell Models and Media for Cancer Research

    Apr 13, 2017, 09:55 by Michael Croft
    WESTBURY, NY - Apr 13, 2017 - BioreclamationIVT, a leading provider of biospecimens and related services, has signed a new distribution partnership agreement with Cellaria, LLC
    Full story

  • New Report Charts Ways To Expedite Critical Research During Epidemics

    Apr 12, 2017, 12:51 by Michael Croft
    STAT |  The report recommends ways to accelerate clinical trials for future epidemics, hoping to ensure that the lessons from the Ebola outbreak are not forgotten.
    Full story

  • SimpleTrials Selected as a Top 10 eClinical Trial Management Solution Provider by Pharma Tech Outlook

    Apr 12, 2017, 12:43 by Michael Croft
    OAKLAND, CA - Apr 12, 2017 - SimpleTrials, the latest Clinical Trial Management System (CTMS) from Trial By Fire Solutions, has been recognized as one of the Top 10 eClinical Trial Management Solution Providers for 2017 by Pharma Tech Outlook Magazine
    Full story

  • PhRMA Seeks More Transparency on FDA Inspections to Speed First-Cycle Approvals

    Apr 11, 2017, 17:54 by Michael Croft
    RAPS |  The Pharmaceutical Research and Manufacturers of America (PhRMA) last week said it supports the US Food and Drug Administration's (FDA) review of its inspection information flow, particularly as applications that receive on-time inspections typically receive first cycle approvals earlier.
    Full story

  • HealthUnlocked appoints new Business Development VP to create further value for pharma & healthcare across its social network

    Apr 11, 2017, 11:34 by Michael Croft
    NEW YORK, NY - Apr 5, 2017 - HealthUnlocked has appointed Nassim Azzi as Vice President of Business Development in the US. The new role will be instrumental in defining and implementing the wider commercial strategy within the U
    Full story

  • Navigating A Connected World: Sensors In Clinical Trials And Care

    Apr 11, 2017, 09:00 by Michael Croft

    Clinical Informatics News | Novartis is hoping to answer the vast questions that surround connected sensor data, and how it might be used to improve drug development, clinical trials, and patient care.

    Full story

  • FDA Delays eCTD Requirements for Master Files

    Apr 7, 2017, 17:05 by Michael Croft
    RAPS | The US Food and Drug Administration (FDA) is giving drugmakers an additional year before requiring master files to be submitted in electronic common technical document (eCTD) format.
    Full story

  • Elsevier Launches Reaxys ChemSearch Challenge and Engineering Academic Challenge for the Next Generation of Chemists and Engineers

    Apr 5, 2017, 11:39 by Michael Croft
    - Apr 5, 2017 - New York, April 5, 2017, Elsevier, the information analytics company specializing in science and health, has announced the launch of two game-based learning challenges, the Reaxys ChemSearch Challenge (CSC) and the Engineering Academic Challenge (EAC)
    Full story

  • Certara’s d3 Medicine Partners with the Australian Department of Defence to Audit the Nation’s Medical Countermeasures Preparedness

    Apr 5, 2017, 08:51 by Michael Croft
    PRINCETON, NJ - Apr 5, 2017 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that its d3 Medicine company has been selected to conduct a national audit of Australia’s medical countermeasures (MCM) product research and development (R&D) capabilities and capacity
    Full story

  • It’s About Time: Clinical Trial Visit Simulations

    Apr 5, 2017, 08:20 by Michael Croft

    Clinical Informatics News | It's About Time | Highlighting new ideas for advancing clinical research, Norman Goldfarb speaks with Faye O’Brien from the Global Medicines Development at AstraZeneca about the need to start simulating clinical trial visits.

    Full story

  • Journal Editor Calls For Culture Change Around Clinical Trial Data

    Apr 4, 2017, 20:10 by Michael Croft
    STAT |  A summit convened by NEJM sought to determine the right balance between sharing data from clinical trials and keeping them private.
    Full story

  • Shortcuts In Drug Testing Can Increase Risk To Patients

    Apr 4, 2017, 13:29 by Michael Croft
    NPR.org |  Researchers use intermediate endpoints, like how a drug lowers cholesterol, to get a quick sense of whether the drug might improve health. But those shortcuts often don't show true benefits and harms.
    Full story

  • Move Over Las Vegas: How To Improve The Odds Of Late-Phase Clinical Trial Success

    Apr 4, 2017, 09:25 by Michael Croft

    Clinical Informatics News Contributed Commentary | The transition from phase 2 to phase 3 of a clinical trial has a very low success rate. Modeling and simulation technologies may serve as pivotal tools for reducing late-stage attrition.

    Full story

  • For Bristol-Myers A Victory And A Mystery

    Apr 3, 2017, 12:20 by Michael Croft
    Forbes |  In a relief to investors, the combination of Opdivo and Yervoy extends survival in melanoma. But to understand why Opdivo did not show a benefit in previously untreated lung cancer, we may need to look more closely at trial design and diagnostic tests.
    Full story

  • The FDA Does Not Care About Health Apps So the Courts Stepped Up

    Apr 3, 2017, 10:03 by Michael Croft
    WIRED |  Last week, the New York Attorney General's office settled lawsuits forcing three app developers to stop promising health-tech miracles.
    Full story

  • CluePoints, PAREXEL, goBalto, And More: News From March 2017

    Mar 31, 2017, 15:05 by Michael Croft

    Clinical Informatics News Brief | News, products, and partnerships from around the clinical trial and healthcare community including news from CluePoints, PAREXEL, goBalto, and more.

    Full story

  • Cenduit to Showcase Advanced Solutions at IRT Europe 2017

    Mar 29, 2017, 16:32 by Michael Croft
    DURHAM, NC, UNITED STATES - Mar 29, 2017 - WHAT:  Cenduit, LLC, the largest interactive response technology (IRT) specialist in the world, is showcasing its solutions and expertise at IRT Europe, April 4-5 in London, England
    Full story

  • Colpitts Clinical Trial Travel Is Set To Manage Its 500th Trial

    Mar 29, 2017, 09:55 by Michael Croft
    NORWOOD, MA - Mar 29, 2017 - On the heels of the globally recognized Rare Disease Day, which this year centered on patient-involved research, Colpitts Clinical Trial Travel has announced that it will manage travel services for its 500th clinical trial this month
    Full story
  • «
  • 231
  • 232
  • 233
  • 234
  • 235 (current)
  • 236
  • 237
  • 238
  • 239
  • 240
  • »